{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:28:50Z","timestamp":1789972130607,"version":"4.0.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.cyto.2014.10.025","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T13:30:54Z","timestamp":1416231054000},"page":"154-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells"],"prefix":"10.1016","volume":"71","author":[{"given":"S.","family":"Ishtiaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sankaralingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Elford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Fogelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hampson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.cyto.2014.10.025_b0005","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/stem.546","article-title":"Concise review: insights from normal bone remodeling and stem cell-based therapies for bone repair","volume":"28","author":"Khosla","year":"2010","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.cyto.2014.10.025_b0010","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1359\/jbmr.2001.16.9.1575","article-title":"Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers","volume":"16","author":"Hauge","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2353\/ajpath.2009.080627","article-title":"A physical mechanism for coupling bone resorption and formation in adult human bone","volume":"174","author":"Andersen","year":"2009","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.cyto.2014.10.025_b0020","first-page":"559","article-title":"Role of angiogenesis on bone formation","volume":"27","author":"Portal-Nunez","year":"2012","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.cyto.2014.10.025_b0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1749-799X-4-19","article-title":"Vascular endothelial growth factor regulates osteoblast survival \u2013 evidence for an autocrine feedback mechanism","volume":"4","author":"Street","year":"2009","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S8756-3282(00)00422-1","article-title":"Tie2 ligands angiopoietin-1 and angiopoietin-2 are coexpressed with vascular endothelial cell growth factor in growing human bone","volume":"28","author":"Horner","year":"2001","journal-title":"Bone"},{"issue":"4 Pt 1","key":"10.1016\/j.cyto.2014.10.025_b0035","doi-asserted-by":"crossref","first-page":"C628","DOI":"10.1152\/ajpcell.1999.277.4.C628","article-title":"Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts","volume":"277","author":"Saadeh","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.cyto.2014.10.025_b0040","doi-asserted-by":"crossref","first-page":"C853","DOI":"10.1152\/ajpcell.2000.278.4.C853","article-title":"VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism","volume":"278","author":"Steinbrech","year":"2000","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5322","key":"10.1016\/j.cyto.2014.10.025_b0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1126\/science.277.5322.48","article-title":"Signaling vascular morphogenesis and maintenance","volume":"277","author":"Hanahan","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-008-9095-3","article-title":"Wnt\/Frizzled signaling in angiogenesis","volume":"11","author":"Zerlin","year":"2008","journal-title":"Angiogenesis"},{"issue":"49","key":"10.1016\/j.cyto.2014.10.025_b0055","doi-asserted-by":"crossref","first-page":"48745","DOI":"10.1074\/jbc.M309193200","article-title":"RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1\/2-dependent mechanism","volume":"278","author":"Henriksen","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.cyto.2014.10.025_b0060","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bbrc.2007.08.099","article-title":"Osteoblast-specific Angiopoietin 1 overexpression increases bone mass","volume":"362","author":"Suzuki","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cyto.2014.10.025_b0065","first-page":"455","article-title":"Clinical role of bisphosphonate therapy","volume":"4","author":"Hampson","year":"2012","journal-title":"Int J Womens Health"},{"issue":"4","key":"10.1016\/j.cyto.2014.10.025_b0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","article-title":"Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras","volume":"13","author":"Luckman","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.cyto.2014.10.025_b0075","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00228-012-1216-7","article-title":"Bisphosphonates: effects on osteoblast","volume":"68","author":"Maruotti","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0080","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.cyto.2014.10.025_b0085","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-008-9104-y","article-title":"Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro","volume":"82","author":"Idris","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"10.1016\/j.cyto.2014.10.025_b0090","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","article-title":"Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw","volume":"22","author":"Compston","year":"2011","journal-title":"Osteoporos Int"},{"issue":"10","key":"10.1016\/j.cyto.2014.10.025_b0095","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.cyto.2014.10.025_b0100","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2010.05768.x","article-title":"Bisphosphonate-related osteonecrosis of the jaw: an overview","volume":"1218","author":"Ruggiero","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cyto.2014.10.025_b0105","article-title":"Atypical femoral fractures: retrospective radiological study of 319 femoral fractures and presentation of clinical cases","author":"Bottai","year":"2013","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.cyto.2014.10.025_b0110","first-page":"2893","article-title":"Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients","volume":"9","author":"Santini","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.cyto.2014.10.025_b0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.tripleo.2011.02.028","article-title":"Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue","volume":"112","author":"Wehrhan","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.24710","article-title":"Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha\/VEGF signaling pathways in human breast cancer cells","volume":"126","author":"Tang","year":"2010","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.cyto.2014.10.025_b0125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2174\/156800909789760285","article-title":"Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects","volume":"9","author":"Marra","year":"2009","journal-title":"Curr Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/14656560903485664","article-title":"Zoledronic acid: an unending tale for an antiresorptive agent","volume":"11","author":"Caraglia","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"10.1016\/j.cyto.2014.10.025_b0135","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0736-0266(01)00048-1","article-title":"The angiogenic response to skeletal injury is preserved in the elderly","volume":"19","author":"Street","year":"2001","journal-title":"J Orthop Res"},{"issue":"2","key":"10.1016\/j.cyto.2014.10.025_b0140","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S8756-3282(02)00950-X","article-title":"Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro","volume":"32","author":"Reffitt","year":"2003","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.cyto.2014.10.025_b0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0039-128X(02)00054-5","article-title":"Dexamethasone and retinoic acid differentially regulate growth and differentiation in an immortalised human clonal bone marrow stromal cell line with osteoblastic characteristics","volume":"67","author":"Ogston","year":"2002","journal-title":"Steroids"},{"key":"10.1016\/j.cyto.2014.10.025_b0150","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"5","key":"10.1016\/j.cyto.2014.10.025_b0155","first-page":"1080","article-title":"Pamidronate induces modifications of circulating angiogenetic factors in cancer patients","volume":"8","author":"Santini","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.cyto.2014.10.025_b0160","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2184.2011.00745.x","article-title":"Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line","volume":"44","author":"Di Salvatore","year":"2011","journal-title":"Cell Prolif"},{"issue":"2A","key":"10.1016\/j.cyto.2014.10.025_b0165","first-page":"933","article-title":"Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model","volume":"28","author":"Soltau","year":"2008","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.cyto.2014.10.025_b0170","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4161\/cbt.10.6.12611","article-title":"Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: phase I ZANTE trial","volume":"10","author":"Facchini","year":"2010","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"10.1016\/j.cyto.2014.10.025_b0175","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.jcms.2011.10.024","article-title":"The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells","volume":"40","author":"Acil","year":"2012","journal-title":"J Craniomaxillofac Surg"},{"issue":"6","key":"10.1016\/j.cyto.2014.10.025_b0180","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.archoralbio.2011.12.007","article-title":"Effects of alendronate on human osteoblast-like MG63 cells and matrix metalloproteinases","volume":"57","author":"Sun","year":"2012","journal-title":"Arch Oral Biol"},{"issue":"6","key":"10.1016\/j.cyto.2014.10.025_b0185","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1172\/JCI115539","article-title":"Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure","volume":"88","author":"Sato","year":"1991","journal-title":"J Clin Invest"},{"issue":"12 suppl","key":"10.1016\/j.cyto.2014.10.025_b0190","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0195","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2008.09.012","article-title":"Osteonecrosis of the jaw: who gets it, and why?","volume":"44","author":"Reid","year":"2009","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.cyto.2014.10.025_b0200","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?","volume":"45","author":"Lesclous","year":"2009","journal-title":"Bone"},{"issue":"13","key":"10.1016\/j.cyto.2014.10.025_b0205","doi-asserted-by":"crossref","first-page":"12794","DOI":"10.1074\/jbc.M308593200","article-title":"ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation","volume":"279","author":"Brown","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.cyto.2014.10.025_b0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1601-0825.2010.01772.x","article-title":"Anatomic site variability in rat skeletal uptake and desorption of fluorescently labeled bisphosphonate","volume":"17","author":"Wen","year":"2011","journal-title":"Oral Dis"},{"issue":"8","key":"10.1016\/j.cyto.2014.10.025_b0215","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.bcp.2011.01.025","article-title":"Dose-dependent differential effects of risedronate on gene expression in osteoblasts","volume":"81","author":"Wang","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.cyto.2014.10.025_b0220","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11010-013-1840-2","article-title":"Osteocyte-induced angiogenesis via VEGF-MAPK-dependent pathways in endothelial cells","volume":"386","author":"Prasadam","year":"2014","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.cyto.2014.10.025_b0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/rheumatology\/kes241","article-title":"There are many potential medical therapies for a traumatic osteonecrosis","volume":"52","author":"Fessel","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.cyto.2014.10.025_b0230","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2012-4039","article-title":"Zoledronic acid acutely increases sclerostin serum levels in women with postmenopausal osteoporosis","volume":"98","author":"Catalano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.cyto.2014.10.025_b0235","doi-asserted-by":"crossref","first-page":"C954","DOI":"10.1152\/ajpcell.00030.2012","article-title":"Vitamin D improves the angiogenic properties of endothelial progenitor cells","volume":"303","author":"Grundmann","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.cyto.2014.10.025_b0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.atherosclerosis.2008.08.020","article-title":"1,25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter","volume":"204","author":"Cardus","year":"2009","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cyto.2014.10.025_b0245","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jbmr.23","article-title":"Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats","volume":"25","author":"Hokugo","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"8","key":"10.1016\/j.cyto.2014.10.025_b0250","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1634\/theoncologist.2012-0141","article-title":"Osteomalacia: the missing link in the pathogenesis of bisphosphonate-related osteonecrosis of the jaws?","volume":"17","author":"Bedogni","year":"2012","journal-title":"Oncologist"},{"issue":"19","key":"10.1016\/j.cyto.2014.10.025_b0255","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","article-title":"Atypical femoral fractures and bisphosphonate use","volume":"362","author":"Girgis","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466614005699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T09:49:41Z","timestamp":1566035381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466614005699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1043466614005699"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2014.10.025","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2014.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}